Literature DB >> 10644301

Proton pump inhibitors for Barrett's oesophagus.

G Triadafilopoulos1.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 10644301      PMCID： PMC1727807          DOI： 10.1136/gut.46.2.144

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  33 in total

1.  Importance of duodenogastric reflux in the surgical outpatient practice.

Authors:  R J Mason; T R DeMeester
Journal:  Hepatogastroenterology       Date:  1999 Jan-Feb

2.  Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal acid reflux in patients with Barrett's esophagus.

Authors:  R Ouatu-Lascar; G Triadafilopoulos
Journal:  Am J Gastroenterol       Date:  1998-05       Impact factor: 10.864

3.  Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus.

Authors:  P Sharma; R E Sampliner; E Camargo
Journal:  Am J Gastroenterol       Date:  1997-04       Impact factor: 10.864

4.  Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis.

Authors:  N Chiba; C J De Gara; J M Wilkinson; R H Hunt
Journal:  Gastroenterology       Date:  1997-06       Impact factor: 22.682

5.  Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease.

Authors:  M F Vaezi; J E Richter
Journal:  Gastroenterology       Date:  1996-11       Impact factor: 22.682

6.  Partial regression of Barrett's esophagus by long-term therapy with high-dose omeprazole.

Authors:  A Malesci; V Savarino; P Zentilin; M Belicchi; G S Mela; G Lapertosa; P Bocchia; G Ronchi; M Franceschi
Journal:  Gastrointest Endosc       Date:  1996-12       Impact factor: 9.427

7.  Prevention of recurrence of oesophageal stricture, a comparison of lansoprazole and high-dose ranitidine.

Authors:  E T Swarbrick; A L Gough; C S Foster; J Christian; A D Garrett; C H Langworthy
Journal:  Eur J Gastroenterol Hepatol       Date:  1996-05       Impact factor: 2.566

8.  Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up.

Authors:  P Sharma; T G Morales; A Bhattacharyya; H S Garewal; R E Sampliner
Journal:  Am J Gastroenterol       Date:  1997-11       Impact factor: 10.864

9.  Features of symptomatic gastroesophageal reflux disease in elderly patients.

Authors:  G Triadafilopoulos; R Sharma
Journal:  Am J Gastroenterol       Date:  1997-11       Impact factor: 10.864

10.  Continuous treatment with omeprazole 20 mg daily for up to 6 years in Barrett's oesophagus.

Authors:  B T Cooper; C S Neumann; M A Cox; T H Iqbal
Journal:  Aliment Pharmacol Ther       Date:  1998-09       Impact factor: 8.171
View more
  10 in total

Review 1.  Surveillance in Barrett's oesophagus: a personal view.

Authors:  K K Basu; J S de Caestecker
Journal:  Postgrad Med J       Date:  2002-05       Impact factor: 2.401

2.  Effect of alpha-tocopherol, N-acetylcysteine and omeprazole on esophageal adenocarcinoma formation in a rat surgical model.

Authors:  Jing Hao; Bin Zhang; Ba Liu; Maojung Lee; Xingpei Hao; Kenneth R Reuhl; Xiaoxin Chen; Chung S Yang
Journal:  Int J Cancer       Date:  2009-03-15       Impact factor: 7.396

3.  The Role of Gastroesophageal Reflux and Other Factors during Progression to Esophageal Adenocarcinoma.

Authors:  William D Hazelton; Kit Curtius; John M Inadomi; Thomas L Vaughan; Rafael Meza; Joel H Rubenstein; Chin Hur; E Georg Luebeck
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-04-30       Impact factor: 4.254

Review 4.  Adult and paediatric GERD: diagnosis, phenotypes and avoidance of excess treatments.

Authors:  Kornilia Nikaki; Philip Woodland; Daniel Sifrim
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-07-27       Impact factor: 46.802

5.  Proton pump inhibitors and vascular function: A prospective cross-over pilot study.

Authors:  Yohannes T Ghebremariam; John P Cooke; Fouzia Khan; Rahul N Thakker; Peter Chang; Nigam H Shah; Kevin T Nead; Nicholas J Leeper
Journal:  Vasc Med       Date:  2015-04-02       Impact factor: 3.239

6.  Bile reflux gastritis and Barrett's oesophagus: further evidence of a role for duodenogastro-oesophageal reflux?

Authors:  M F Dixon; P M Neville; N P Mapstone; P Moayyedi; A T Axon
Journal:  Gut       Date:  2001-09       Impact factor: 23.059

7.  Dysplasia in Barrett's Esophagus.

Authors:  Marcos Pedrosa
Journal:  Curr Treat Options Gastroenterol       Date:  2001-02

Review 8.  Treatment for Barrett's oesophagus.

Authors:  Jonathan Re Rees; Pierre Lao-Sirieix; Angela Wong; Rebecca C Fitzgerald
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

Review 9.  The role of proton pump inhibitors in gastro-oesophageal reflux disease.

Authors:  Roy Dekel; Chad Morse; Ronnie Fass
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 10.  Melatonin in Prevention of the Sequence from Reflux Esophagitis to Barrett's Esophagus and Esophageal Adenocarcinoma: Experimental and Clinical Perspectives.

Authors:  Jolanta Majka; Mateusz Wierdak; Iwona Brzozowska; Marcin Magierowski; Aleksandra Szlachcic; Dagmara Wojcik; Slawomir Kwiecien; Katarzyna Magierowska; Jacek Zagajewski; Tomasz Brzozowski
Journal:  Int J Mol Sci       Date:  2018-07-13       Impact factor: 5.923
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.